1-(4-(sec-Butyl)phenyl)-5-oxopyrrolidine-3-carboxylic acid

Catalog No. :
ACHUCA047
CAS No. :
63674-58-8
Molecular Formula :
C15H19NO3
Molecular Weight :
261.32

IUPAC Name:1-(4-(sec-butyl)phenyl)-5-oxopyrrolidine-3-carboxylic acid

1-(4-(sec-Butyl)phenyl)-5-oxopyrrolidine-3-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$155.00Login to see priceInquiryInquiry
1g95%$388.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(4-(sec-Butyl)phenyl)-5-oxopyrrolidine-3-carboxylic acid
IUPAC Name1-(4-(sec-butyl)phenyl)-5-oxopyrrolidine-3-carboxylic acid
MDL No.MFCD02197524
Molecular FormulaC15H19NO3
Molecular Weight261.32
SMILESO=C(C(C1)CN(C2=CC=C(C(C)CC)C=C2)C1=O)O
InChI KeyQQDZRLNEBVHNOB-UHFFFAOYSA-N
Synonym1-(4-sec-Butylphenyl)-5-oxopyrrolidine-3-carboxylic acid;1-(4-butan-2-ylphenyl)-5-oxo-pyrrolidine-3-carboxylic acid;1-(4-butan-2-ylphenyl)-5-oxopyrrolidine-3-carboxylic acid;5-keto-1-(4-sec-butylphenyl)pyrrolidine-3-carboxylic acid;5-oxo-1-(4-sec-butylphenyl)-3-pyrrolidinecarboxylic acid;5-oxo-1-(4-sec-butylphenyl)pyrrolidine-3-carboxylic acid;BAS 04900440;STK092007
CAS No.63674-58-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACHUCA047 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHUCA047 route product structure diagram
    ACHUCA04763674-58-8
Inquiry

2. ACHUCA047 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHUCA047 route product structure diagram
    ACHUCA04763674-58-8
Inquiry

Comments (0)